推荐应用
SCF protein (Stem Cell Factor), also known as Kit Ligand-1 (KL-1), is a multifunctional cytokine protein that plays an important role in biological processes such as cell proliferation, differentiation, and survival. The SCF protein primarily exerts its effects by binding to its receptor c-Kit. c-Kit is a tyrosine kinase receptor that is widely expressed in various cell types. The binding of SCF to c-Kit activates multiple signaling pathways, including PI3K/Akt, MAPK, STAT, etc., thereby regulating cell growth, proliferation, and differentiation.
SCF protein plays a crucial role in the hematopoietic system, particularly in the proliferation and differentiation of stem cells. In diseases, SCF protein also plays a significant role. Aberrant activation of the SCF/c-Kit signaling pathway may lead to the development of certain diseases, such as tumors. Therefore, SCF protein and its receptor c-Kit could potentially serve as therapeutic targets for certain diseases.
高纯度、高活性、低内毒素、高批间一致性
SDS-PAGE

Figure 1.On SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Bioactivity-ELISA

Figure 2. Biotinylated Human SCF Protein,His-Avi Tag was immobilized at 1 μg/ml (100 μL/well) on streptavidin precoated. Increasing concentrations of Human c-Kit(CD117) Protein; hFc Tag were added.
-85 ~ -65℃保存,收到货之日起,6个月有效期。避免反复冻融,建议等分分装为一次实验使用量,分装后,-80℃冻存。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
89
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
81
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
108
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
89
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1814
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1800
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1087
2026-04-22
【应用方向】TNFR蛋白家族概述
1030
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1179
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
888
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
910
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
948
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
824
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19372
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11563
2025-07-09





